DESMOID TUMORS OF THE ABDOMINAL WALL AND THE THERAPEUTIC MANAGEMENT: CASE REPORT

被引:0
作者
Hachim, H. [1 ]
Alaoui, M. [1 ]
Mountasser, M. [1 ]
Majbar, A. [1 ]
Sabbah, F. [1 ]
Raiss, M. [1 ]
Hrora, A. [1 ]
Ahallat, M. [1 ]
机构
[1] Ibn Sina Univ Hosp, Surg Clin C, Rabat, Morocco
来源
JOURNAL OF MEDICAL AND SURGICAL RESEARCH | 2015年 / 2卷 / 02期
关键词
abdominal wall; Aggressive fibromatosis; desmoid tumor; infiltrated margins;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Desmoid tumors are fibrous proliferations with an aggressive and infiltrating character which tend to recur locally without giving any metastasis. They are rare, representing less than 0.03% of all tumors. Mostly, they are sporadic, but in 2% of the cases they could come in a genetic context "The Gardner Syndrome". Desmoid tumors are localized, appearing in a decreasing order of frequency in the structures of the abdominal wall; the peripheral muscle fascia or more rarely in the intra-abdominal contents (mesentery, retroperitoneum). We report here the case of a 32 years old female patient who had a desmoid tumor of the abdominal wall discovered during pregnancy. From this clinical case, we will focus on the difficulties of their therapeutic management, recalling through a literature review: the clinical, paraclinical and therapeutic features of those tumors.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 25 条
[1]   Update on the management of desmoids tumors [J].
Aissa, A. ;
Alouini-Mekki, R. ;
Ben Abdallah, A. ;
Enaifar, R. ;
Kobbi, I. ;
Stita, W. ;
Boulifi, A. .
GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2012, 40 (02) :104-108
[2]   Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors [J].
Bandipalliam, P ;
Balmana, J ;
Syngal, S .
SURGERY, 2004, 135 (06) :683-689
[3]   Desmoid tumors in familial adenomatous polyposis [J].
Cotte, E ;
Glehen, O ;
Monneuse, O ;
Cotton, F ;
Vignal, J .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (6-7) :574-581
[4]  
D'Alteroche L, 1998, GASTROEN CLIN BIOL, V22, P1098
[5]  
Dequanter D, 2002, J CHIR-PARIS, V139, P236
[6]  
Elias D, 2000, PRESSE MED, V29, P408
[7]  
FAYCAL O, 2005, J PEDIAT PUERIC, V18, P62, DOI DOI 10.1016/J.JPP.2005.01.002
[8]   Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis [J].
Gounder, Mrinal M. ;
Lefkowitz, Robert A. ;
Keohan, Mary Louise ;
D'Adamo, David R. ;
Hameed, Meera ;
Antonescu, Cristina R. ;
Singer, Samuel ;
Stout, Katherine ;
Ahn, Linda ;
Maki, Robert G. .
CLINICAL CANCER RESEARCH, 2011, 17 (12) :4082-4090
[9]   Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor) [J].
Heinrich, MC ;
McArthur, GA ;
Demetri, GD ;
Joensuu, H ;
Bono, P ;
Herrmann, R ;
Hirte, H ;
Cresta, S ;
Koslin, DB ;
Corless, CL ;
Dirnhofer, S ;
van Oosterom, AT ;
Nikolova, Z ;
Dimitrijevic, S ;
Fletcher, JA .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1195-1203
[10]   The pharmacological treatment of aggressive fibromatosis: a systematic review [J].
Janinis, J ;
Patriki, M ;
Vini, L ;
Aravantinos, G ;
Whelan, JS .
ANNALS OF ONCOLOGY, 2003, 14 (02) :181-190